Straits Times Index
3,292.93 -3.96 (-0.12%) Nikkei
38,236.07 -37.98 (-0.10%) Hang Seng
18,475.92 +268.79 (+1.48%) FTSE 100
8,213.49 +41.34 (+0.51%) Bitcoin USD
63,729.92 +2,111.32 (+3.43%) CMC Crypto 200
1,359.39 +82.41 (+6.45%)
Carmat (CXT.BE)
| Previous close | 2.9200 |
| Open | 2.9100 |
| Bid | 2.9250 x N/A |
| Ask | 3.2250 x N/A |
| Day's range | 2.9100 - 3.0850 |
| 52-week range | 2.9050 - 8.2600 |
| Volume | |
| Avg. volume | 0 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 24 Apr 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Business WireCARMAT : Availability of the 2023 Universal Registration Document
PARIS, April 30, 2024--Regulatory News: CARMAT (FR0010907956, ALCAR), designer and developer of the world’s most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering from advanced biventricular heart failure (the "Company" or "CARMAT"), today announced the publication of the Company’s Universal registration document ("URD") for the year ended December 31, 2023.
Business WireCARMAT Announces Its 2023 Annual Results and Provides an Update on Its Progress and Prospects for 2024
PARIS, April 24, 2024--CARMAT announces its 2023 annual results and provides an update on its progress and prospects for 2024
Business WireCARMAT Announces Its Participation in Several Scientific and Investor Conferences During the Second Quarter of 2024
PARIS, April 04, 2024--Regulatory News: CARMAT (FR0010907956, ALCAR), designer and developer of the world’s most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering from advanced biventricular heart failure (the "Company" or "CARMAT"), announces today its participation in the following scientific and investor conferences during the second quarter of 2024:
